Dr Reddy’s inks pact value USD150 million with Citius Pharma to promote all rights to anti-cancer agent E7777

Dr Reddy’s Laboratories on Saturday mentioned it has inked a pact with US-based Citius Prescription drugs to promote its rights to an anti-cancer agent.  The drug agency mentioned it has entered right into a definitive settlement with Citius to promote all of its rights to E7777 (an engineered IL-2-diphtheria toxin fusion protein) and sure associated belongings.  Underneath the phrases … Read more